CytomX Therapeutics Inc. (CTMX)
NASDAQ · Healthcare
CytomX Therapeutics Inc. Shareholder Equity 2013–2025
CytomX Therapeutics Inc. annual shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- CytomX Therapeutics Inc. shareholder equity as of December 31, 2025: 99.0M, a 21812.28% decrease year-over-year.
- CytomX Therapeutics Inc. shareholder equity for 2025 were 99.0M, a 21812.28% decrease from 2024.
- CytomX Therapeutics Inc. shareholder equity for 2024 were -456,000, a 99.04% decrease from 2023.
- CytomX Therapeutics Inc. shareholder equity for 2023 were -47.4M, a 44.67% decrease from 2022.
- CytomX Therapeutics Inc. shareholder equity for 2022 were -85.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| CytomX Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $99 |
| 2024 | $-0 |
| 2023 | $-47 |
| 2022 | $-86 |
| 2021 | $-0 |
| 2020 | $-8 |
| 2019 | $25 |
| 2018 | $136 |
| 2017 | $70 |
| 2016 | $78 |
| 2015 | $126 |
| 2014 | $-79 |
CytomX Therapeutics Inc. Shareholder Equity — FAQ
CytomX Therapeutics Inc. (CTMX) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTMX's shareholder equity history?
The chart and table above show CytomX Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.